FDA Inspection 1100281 — Trifarma S.p.A.

Trifarma S.p.A. — FEI 3002807260

The FDA completed an inspection of Trifarma S.p.A. on February 28, 2019 in Rozzano. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 28, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rozzano (Italy)

Additional Details

Mutual Recognition Agreement (MRA)